Qamar Khan

July 2024 · 2 minute read

Professional Background

Qamar J. Khan, MD, is a professor of medicine at the University of Kansas School of Medicine in Kansas City, KS. Dr Khan received his medical degree from King Edward’s Medical College in Pakistan. He completed his internship and residency at Bridgeport Hospital, Yale University in Bridgeport, CT and his fellowship at the University of Kansas Medical Center. He is board certified in internal medicine for both medical oncology and hematology.

Dr Khan is a breast oncologist with a focus on treatment of breast cancer. Since joining the faculty in the division of hematology and oncology at the university, he has been involved in the design and conduct of clinical trials, especially investigator-initiated trials (IITs). Dr Khan has designed and received funding for several IITs. His main area of research is neo-adjuvant therapy for breast cancer.

Dr Khan is the Director of Breast Oncology Program at KU and serves as the Chair of the KU Protocol Review and Monitoring Committee (PRMC). PRMC conducts independent scientific reviews and bio statistical reviews of all trials being initiated at the cancer center, is responsible for prioritization of new trials to ensure the availability of adequate patient numbers and resources, and conducts monitoring of activated protocols for their continued scientific relevance and accrual.

Dr Khan has been awarded the University of Kansas Cancer Center Director’s Clinic Trial Accrual Award and the University of Kansas Medical Center Top Doc Award. Dr Khan has numerous submitted articles in peer-reviewed journals, including Cancer Epidemiology Biomarkers and Prevention, Breast Cancer Research and Treatment, Supportive Care in Cancer, Clinical Cancer Research, and The New England Journal of Medicine.

ncG1vNJzZmivp6x7rMHMnGWenKVkvqy0wKdloaydoQ%3D%3D